Multiple Sclerosis and Autoimmune Neurology Update 2027
Multiple Sclerosis and Autoimmune Neurology Update 2027 will provide healthcare professionals with clinical and research updates across multiple sclerosis and autoimmune neurological disorders.
The programme will combine lectures, case vignettes and interactive discussions with expert presenters. Topics include differentiating multiple sclerosis, neuromyelitis optica spectrum disorder and MOG antibody disease, neurological infections associated with immunosuppressant medicines, neural antibody testing and treatment approaches for autoimmune encephalitis.
Sessions will also address novel BTK inhibitors in multiple sclerosis and updated diagnostic criteria for neuromyelitis optica spectrum disorder.
The course is aimed at physicians, nurses, allied health professionals, pharmacists, physical and occupational therapists, social workers and other healthcare professionals. Participants can attend in person in Hawaii or via livestream.
The programme offers up to 17 credits across several professional accreditation categories.
Where:
The Westin Hapuna Beach Resort
Waimea, Hawaii
US
Livestream attendance is also available.
When:
1–4 February 2027
Starts: 4:30 pm GMT on 1 February
Ends: 10:40 pm GMT on 4 February
(Local Hawaii times: 6:30 am on 1 February to 12:40 pm on 4 February.)
Tickets:
M.D., D.O., Ph.D.: $1,195
Allied Health, NP, PA, Retirees: $975
Why attend?
- Review current evidence and practical care strategies for multiple sclerosis and autoimmune neurology.
- Explore diagnosis and differentiation of MS, NMOSD and MOGAD.
- Examine treatment approaches for autoimmune encephalitis and neurological complications associated with immunosuppressant medicines.
- Learn about emerging therapies including novel BTK inhibitors.
- Attend in person in Hawaii or participate through the livestream option.
EVENT WEBSITE:
ORGANISER:
Mayo Clinic
